Deficiency or opportunity?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N R Dunnick.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVE: To describe a quality improvement process that was initiated in a Department of Radiology to reduce the number of incomplete or "lost" imaging studies and decrease the time from the initiation of an imaging study to printing of the final report. METHODS: Incomplete cases were defined as those imaging studies that did not have a signed final report more than 3 days and less than 90 days after imaging. A computer program was written to generate a monthly incomplete case list from the radiology information system database; each step in the process, from patient arrival to final report printing, was analyzed and a list of root causes (for the incomplete cases) was developed. Short- and long-term interventions were introduced and the effects were monitored from 1992-1999. RESULTS: Problems were identified at each step in the process. Although some of the root causes originated outside the authority of the Department of Radiology, interventions we implemented within the department reduced the incomplete list by 72%, from a high of 2.8% of all imaging examinations to less than 0.8%. Continual monitoring of the problem is necessary to maintain this level. CONCLUSION: The number of incomplete or "lost" imaging studies can be decreased using a continuous quality improvement process. This leads to improved patient care and increased revenue.
Explore the source record for details and available documents.
OBJECTIVE: Although representing a minority of adrenal adenomas, the lipid-poor variety cannot be accurately identified on unenhanced CT or chemical shift MR imaging. We compared the delayed contrast-enhanced CT features of lipid-poor adenomas with those of lipid-rich adenomas and of adrenal nonadenomas to determine whether there were differences in the washout features between these groups of lesions. SUBJECTS AND METHODS: Eighteen proven lipid-poor adenomas, 56 lipid-rich adenomas, and 40 adrenal nonadenomas underwent CT before, immediately after, and 15 min delay after IV contrast injection. Region-of-interest measurements were made of all adrenal lesions at the three time points. The degree of enhancement, enhancement washout, percentage enhancement washout, and relative percentage enhancement washout were calculated for each adrenal mass. Pooled data were analyzed statistically. Optimal threshold values for diagnosing adrenal adenomas were also determined. RESULTS: The mean CT attenuation of lipid-poor adenomas was significantly higher than that of lipid-rich adenomas at all three phases but not significantly different from that of nonadenomas. The mean percentage enhancement washout on images obtained 15 min after administration of contrast material was similar for lipid-rich and lipid-poor adenomas but was significantly higher than that of nonadenomas. The mean relative percentage enhancement washout was significantly different among all three groups. CONCLUSION: Lipid-poor adenomas cannot be differentiated from adrenal nonadenomas on the basis of a single mean attenuation value. However, lipid-poor adrenal adenomas show enhancement and enhancement washout features nearly identical to lipid-rich adenomas and can be distinguished from nonadenomas on the basis of a percentage washout threshold value of 60% and a relative percentage washout of 40%.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVE: The purpose of this study was to analyze the CT contrast enhancement washout curves of adrenal masses and to determine the earliest time after initial enhancement that differentiation of adenomas from nonadenomas is possible. MATERIALS AND METHODS: Contrast enhancement washout curves were generated after delayed contrast-enhanced CT scans of 52 adrenal adenomas and 24 nonadenomas. The optimal threshold value and corresponding sensitivity and specificity for the diagnosis of adenoma were determined according to attenuation values. Also, we calculated the percentage and relative percentage of enhancement washout at time delays from 5 to 45 min after initial enhancement. RESULTS: The mean percentage of enhancement washout for adrenal adenomas was 51% at 5 min and 70% at 15 min, compared with 8% and 20%, respectively, for nonadenomas. The sensitivity and specificity for the diagnosis of adenoma were both 96% at a threshold attenuation value of 37 H on the 15-min delayed enhanced scan. CONCLUSION: On CT, adrenal adenomas show a much earlier and more rapid washout of contrast enhancement than do nonadenomas. Adenomas and nonadenomas can be differentiated by attenuation values or the percentage or relative percentage of washout as early as 5-15 min after enhancement.
Explore the source record for details and available documents.
RATIONALE AND OBJECTIVES: The authors assessed the frequency, sequelae, and risk factors of extravasation of intravenously administered iodinated contrast media. MATERIALS AND METHODS: All patients with local reactions after intravenous injection of contrast media between November 1994 and December 1996 were studied. Comparison was made with data obtained from a control group of 100 patients with no local reactions who underwent contrast material-enhanced computed tomography (CT). RESULTS: Local reactions were reported in 56 (0.25%) of 22,254 patients who received intravenous injections of iodinated contrast media. Fifty-one patients experienced extravasation, and five patients experienced local irritation in the absence of clinically detectable extravasation. Extravasation occurred during CT (n = 46), urography (n = 4), and venography (n = 1). Contrast material was nonionic in 37 cases and conventional ionic in 14 cases of extravasation. Extravasated volumes exceeded 30 mL in 22 patients and 100 mL in six patients. Forty-five (80%) of 56 patients with local reactions had complete resolution of symptoms within 24 hours. Only four patients had symptoms for more than 48 hours. No surgery was required. Compared with the control group, patients with extravasation were significantly more likely to have been injected with small-bore catheters (21 or 22 gauge) and to have been injected at low or high rates. CONCLUSION: Symptoms of contrast medium extravasation usually resolve quickly. In patients with extravasation, injections are more likely to have been performed with techniques that vary from normal practice.
To define the clinical characteristics of renovascular hypertension (RVH) and determine the clinical usefulness of captopril stimulated peripheral renin and postcaptopril renography in blacks at risk for RVH, 79 clinically selected hypertensive blacks were evaluated. Unstimulated (U-PRA), captopril stimulated (S-PRA) peripheral renin, and postcaptopril renography (PC-RENO) were obtained. All subjects underwent conventional renal arteriography. Renal artery stenosis (RAS) was present in 14 of 79 (18%) patients. Renovascular hypertension (RVH) was found in 7 of 79 (9%) patients. S-PRA had a sensitivity and specificity of 38% and 86% respectively to detect RAS; and a sensitivity and a specificity of 17% and 85% respectively to detect RVH. PC-RENO had a sensitivity and a specificity of 64% and 58% respectively to detect RAS; and a sensitivity and a specificity of 67% and 58% respectively to detect RVH. This study suggests that RAS occurs in 18% of clinically selected hypertensive blacks. RVH was present in 9% of this population. Captopril stimulated peripheral renin and postcaptopril renography are not useful as screening tools for the diagnosis of renovascular disease in blacks. Blacks at high risk should be evaluated with angiography.
RATIONALE AND OBJECTIVES: We assessed the effects on the perceived quality of faculty teaching of a resident evaluation form that solicits specific comments on faculty strengths and weaknesses. METHODS: An evaluation form was devised that rated faculty on a scale of 1-10 in teaching conference quality, availability, efficiency, and teaching. The form requested constructive comments on faculty strengths and weaknesses. The forms were completed anonymously by residents at all levels. Individual results and means for the department were tabulated and provided to each faculty member in a personal interview. Change in performance was assessed by comparing faculty evaluation scores for 2 consecutive years. RESULTS: The mean faculty scores for teaching conference quality, availability, efficiency, and teaching increased from 7.8, 7.9, 7.9, and 7.7 to 8.1, 8.3, 8.3, and 8.1 in each of the respective areas. The scores of the faculty members who initially received the 10 lowest scores rose to an even greater extent (from 6.2, 6.2, 6.0, and 6.0 to 6.8, 7.4, 7.3, and 6.8 in each of the respective areas), whereas the scores of the faculty members who initially received the 10 highest scores remained relatively constant. CONCLUSION: The perceived quality of certain focused aspects of resident teaching can be modified by use of resident evaluations that solicit specific suggestions for improvement. With appropriate feedback, this is an effective tool for improving the teaching performance of radiology department faculty, particularly those considered to be the weakest teachers.
PURPOSE: To determine whether adenomas can be differentiated from nonadenomas on 1-hour-delayed enhanced computed tomographic (CT) scans. MATERIALS AND METHODS: In a prospective evaluation of 51 adrenal masses in 39 patients, the CT attenuation was measured at the time of contrast enhancement and 1 hour later. The results were compared for adenomas (n = 41) and metastases (n = 10). RESULTS: On 1-hour-delayed enhanced CT scans, the mean attenuation of the adenomas was 11 HU +/- 13 versus 49 HU +/- 8.3 for metastases (P < .001). At a threshold value of 30 HU, specificity and positive predictive value for the diagnosis of adenoma were 100% with a sensitivity of 95%. The mean decrease in attenuation during the 1-hour delay was 74% +/- 37 for the adenomas versus 31% +/- 28 for the metastases (P < .001). CONCLUSION: CT densitometry on delayed scans obtained 1 hour after contrast enhancement may be useful in characterizing an adrenal mass as an adenoma. When CT is performed with a 150-mL bolus injection of contrast material and with the scanning parameters described in this study, other procedures or imaging studies may be unnecessary if the mass measures less than 30 HU on the delayed scans.
PURPOSE: To assess the relationship between the quantity of lipid in resected adrenal adenomas and the unenhanced computed tomographic (CT) attenuation number and the relative change in signal intensity on chemical shift magnetic resonance (MR) images. MATERIALS AND METHODS: The percentage of lipid-rich cortical cells in histologic sections from 20 resected adrenal adenomas was assessed. The results were correlated with the corresponding unenhanced CT attenuation number or the relative change in signal intensity on chemical shift MR images, or both. RESULTS: There was an inverse linear relationship between the percentage of lipid-rich cortical cells in the adrenal adenomas and the unenhanced CT attenuation number (R2 = .68, P = .0005). There was a similar inverse linear relationship to the relative change in MR signal intensity on chemical shift images by using both quantitative (R2 = .83, P = .004) and qualitative (R2 = .70, P = .019) assessment. CONCLUSION: The presence and amount of histologic lipid in many adrenal adenomas accounts for their low attenuation on unenhanced CT scans and their loss in relative signal intensity on chemical shift MR images.
OBJECTIVE: The purpose of our study was to determine whether unenhanced CT attenuation value, enhanced CT attenuation value, or lesion size can be used to differentiate adrenal adenomas from nonadenomatous adrenal masses. MATERIALS AND METHODS: We retrospectively assessed the CT scans of 135 adrenal masses in 124 patients with a variety of adrenal masses. There were 93 cortical adenomas (85 nonhyperfunctioning adenomas, four Cushing's adenomas, and four primary aldosteronism adenomas). The nonadenomas consisted of 34 metastases, four cortical carcinomas, and four pheochromocytomas. The scattergrams and mean values of the size and attenuation values on enhanced and unenhanced scans were correlated with the final diagnoses. Results were also subjected to receiver operating characteristic analysis. RESULTS: Forty-one adenomas and 20 nonadenomas had unenhanced CT. The mean attenuation value of the 41 adenomas was significantly lower (p < .001) than that of the nonadenomas (2.5 H +/- 14 compared with 32 H +/- 6.4). The lowest unenhanced CT attenuation value of the nonadenomas was 18 H; therefore, the sensitivity:specificity ratio for the diagnosis of adenomas was 85%:100% at a threshold value of 18 H. At this threshold, the positive predictive value was 100% and the negative predictive value was 77%. For the 85 masses with enhanced CT, the mean attenuation of the 60 adenomas was also significantly lower (p < .01) than for the 25 nonadenomas (47 H +/- 24 compared with 62 H +/- 21). The lowest enhanced CT attenuation value of the nonadenomas was also 18 H, but the sensitivity:specificity ratio was only 10%:100% at this threshold value of 18 H. Although the mean diameter of the adenomas was significantly lower (p < .001) than for the nonadenomas (2.4 cm +/- 0.9 compared with 4.5 cm +/- 2.5), there was sufficient overlap between the two groups at the smallest sizes that a threshold value for a highly specific diagnosis of adenoma was not present. The area under the receiver operating characteristic curve for unenhanced CT attenuation values (0.98 +/- 0.02) was significantly greater than the area for enhanced CT values (0.68 +/- 0.06, p < .001) and the area for size (0.79 +/- 0.04, p < .001). CONCLUSIONS: Unenhanced CT attenuation values can characterize an adrenal mass as a benign adenoma with high specificity and acceptable sensitivity. Adrenal masses cannot be characterized using enhanced CT attenuation values or lesion size.
Explore the source record for details and available documents.
Explore the source record for details and available documents.